Detalhe da pesquisa
1.
Multimodal platform for assessing drug distribution and response in clinical trials.
Neuro Oncol
; 24(1): 64-77, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383057
2.
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.
Neuro Oncol
; 23(12): 2042-2053, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050676
3.
Quantifying Glioblastoma Drug Response Dynamics Incorporating Treatment Sensitivity and Blood Brain Barrier Penetrance From Experimental Data.
Front Physiol
; 11: 830, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32973540